APA (7th ed.) Citation

Cabezas, J., Vázquez, I. F., Llerena, S., Carrión, J. A., Moya, A. G., Lens, S., . . . Crespo, J. (2019). FRI-225-Universal access to direct-acting antivirals treatment is not not enough to prevent late stage presentation of hepatitis C infection. Journal of Hepatology, 70, e493. https://doi.org/10.1016/S0618-8278(19)30970-3

Chicago Style (17th ed.) Citation

Cabezas, Joaquin, et al. "FRI-225-Universal Access to Direct-acting Antivirals Treatment Is Not Not Enough to Prevent Late Stage Presentation of Hepatitis C Infection." Journal of Hepatology 70 (2019): e493. https://doi.org/10.1016/S0618-8278(19)30970-3.

MLA (9th ed.) Citation

Cabezas, Joaquin, et al. "FRI-225-Universal Access to Direct-acting Antivirals Treatment Is Not Not Enough to Prevent Late Stage Presentation of Hepatitis C Infection." Journal of Hepatology, vol. 70, 2019, p. e493, https://doi.org/10.1016/S0618-8278(19)30970-3.